Integrating QoL Analysis With Efficacy Outcomes in the Pembrolizumab KN-590 Study in First-Line Esophageal Cancer from qol Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: In this video, Prof Eric Van Cutsem, MD, PhD, and Marc Diez Garcia, MD, discuss new data from the Q-TWIST analysis of the phase 3 KEYNOTE-590 study of first line pembrolizumab plus chemotherapy in esopahgeal and gastroesophageal junction cancer.
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)